Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.

@article{Stojakovi2010LowdoseAI,
  title={Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.},
  author={Tatjana Stojakovi{\'c} and Thierry Claudel and Csilla Putz-Bankuti and Guenter Fauler and Hubert Scharnagl and Martin Otto Werner Wagner and Harald Sourij and Rudolf E. Stauber and Karl Winkler and Winfried Maerz and Thomas C. Wascher and Michael Trauner},
  journal={Atherosclerosis},
  year={2010},
  volume={209 1},
  pages={178-83}
}
OBJECTIVE Primary biliary cirrhosis (PBC) is frequently associated with hypercholesterolemia and with an increased cardiovascular morbidity and mortality. Statins lower serum cholesterol levels and may thus improve the cardiovascular risk in PBC patients. The aim of our study was to prospectively examine the efficacy of low-dose atorvastatin on cholestasis as well as cardiovascular risk markers such as dyslipidemia and vascular function in patients with PBC. METHODS Nineteen patients with… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Similar Papers

Loading similar papers…